Professional Medical Expertise Co. (9574.SR) — Cash flow
Operating, investing, and financing cash flow for Professional Medical Expertise Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 42↑50.8% | 28↑11.3% | 25↑30.7% | 19↓7.8% | 21 | |
| Depreciation & Amortization | 9↑76.0% | 5↓10.3% | 5↑77.6% | 3↑29.4% | 2 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -72↓39.6% | -52↓49.0% | -35↓6.9% | -32↓373.4% | -7 | |
| Accounts Receivable | -91↓1301.9% | -7↑84.3% | -41↓174.5% | -15↑54.5% | -33 | |
| Inventory | -9↑71.2% | -32↑20.1% | -40↓60.5% | -25↓88.2% | -13 | |
| Accounts Payable | 23↑406.6% | -8↓115.9% | 48↑586.4% | 7↓75.8% | 29 | |
| Other Working Capital | 5↑194.0% | -5↓762.8% | -0.62↓175.4% | 0.82↓92.5% | 11 | |
| Other Non-Cash Items | 12↓32.3% | 17↑68.1% | 10↑378.7% | 2↓9.4% | 2 | |
| Net Cash from Operating Activities | -10↓443.3% | -2↓132.0% | 6↑171.2% | -8↓144.6% | 19 | |
| Operating Cash Flow | -10↑16.6% | -12↓308.2% | 6↑171.2% | -8↓144.6% | 19 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -24↓268.5% | -7↑26.8% | -9↓37.9% | -7↓95.0% | -3 | |
| Capital Expenditure | -24↓268.5% | -7↑26.8% | -9↓37.9% | -7↓95.0% | -3 | |
| Acquisitions | 8↑143.1% | 3 | 0.00↓100.0% | 0.12 | 0.00 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00↓100.0% | 2 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -16↓408.2% | -3↑54.3% | -7↓6.4% | -6↓91.4% | -3 | |
| Financing Activities | ||||||
| Net Debt Issuance | 31↑0.7% | 31↑568.2% | 5↓75.2% | 19↑2886.0% | 0.63 | |
| Long-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.47 | |
| Short-Term Net Debt Issuance | 31↑0.7% | 31↑568.2% | 5↓75.2% | 19↑2886.0% | 0.63 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -4↑64.9% | -10 | 0.00↑100.0% | -16↓451.7% | -3 | |
| Common Dividends Paid | -4↑64.9% | -10 | 0.00↑100.0% | -16↓451.7% | -3 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -3↑76.5% | -12↓50.8% | -8↓1180.6% | -0.63↓35.8% | -0.47 | |
| Net Cash from Financing Activities | 25↑179.7% | 9↑359.4% | -3↓259.3% | 2↑179.0% | -3 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -1↓126.5% | 4↑190.3% | -4↑65.1% | -12↓200.5% | 12 | |
| Cash at Beginning of Period | 5↑414.1% | 0.95↓82.1% | 5↓70.1% | 18↑231.2% | 5 | |
| Cash at End of Period | 4↓21.3% | 5↑414.1% | 0.95↓82.1% | 5↓70.1% | 18 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -34↓83.0% | -19↓507.3% | -3↑79.0% | -15↓197.4% | 15 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.